Super: a Joint System in a Rehabilitation Educational Digital Platform (SUPER)

November 23, 2022 updated by: Giulia Purpura, University of Milano Bicocca

Feasibility Study About Super Digital Platform: a Joint System for Rehabilitation and Educational Projects for Children With Autism Spectrum Disorder

Due to its complexity and variability, Autism Spectrum Disorder (ASD) requires multidisciplinary and multidimensional interventions. SUPER (in Italian: Sistema Unitario in una Piattaforma Riabilitativa ed Educativa) is an Italian digital platform, implemented to facilitate collaboration between families, health services, and schools and to promote personalized intervention for children with ASD. The research protocol, aimed to test SUPER's feasibility and usability, foresees the enrollment of 12 ASD children in the Experimental Group (EG) and 12 ASD children for the Control Group. All families, teachers, and clinicians will perform usual rehabilitative and educative interventions, but the EG will use SUPER, in addition to ordinary programs. The feasibility and acceptability of SUPER will be assessed through usability scales and questionnaires realized ad hoc for the purpose. At baseline and established endpoints, ASD patients will be evaluated with different assessment tools.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

24

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Monza, Italy, 20128
        • Recruiting
        • ASST Monza, University of Milano Bicocca
        • Contact:
        • Sub-Investigator:
          • Luca Tagliabue
      • Pompei, Italy, 80045
        • Recruiting
        • Centro Riabilitativo Pompei
        • Contact:
        • Sub-Investigator:
          • Ersilia Vallefuoco

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 7 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Children with Autism Spectrum Disorders that perform rehabilitative programs

Description

Inclusion Criteria:

  • Diagnosis of Autism Spectrum Disorder
  • Access to Child Neuropsychiatry or Pediatric Rehabilitation services participating in the study
  • Age of patients from 3 to 7,11 years
  • Informed consent freely acquired before the start of the study by the patient's parents

Exclusion Criteria:

  • Patients with severe genetic degenerative diseases
  • Patients with severe sensory disabilities
  • Patients with severe medical complications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Experimental Group
Families, teachers, and clinicians use SUPER digital platform in addition to usual rehabilitative and educative interventions.
SUPER digital platform was implemented to ensure synergy between ASD families, health services, and schools through different tools to share rehabilitative and educational objectives and strategies. It was designed following the ASD International Guidelines and the recommendations of the ICF-CY and was organized into two areas: General (to promote scientific knowledge on ASD) and Personalized (restricted virtual space for groups of users following an individual with ASD).
Control Group
Families, teachers, and clinicians perform usual rehabilitative and educative interventions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline at 3 months in a specific questionnaire that evaluates perception of taking charge
Time Frame: T0 (baseline) and T1 (after 3 months)
Questionnaire created ad hoc for taking charge: it is a parent-report instrument with 22 items based on a 5-points Likert Scale. Higher scores (maximum 110) mean a better perception of taking charge, while lower scores (minimum 22) mean a worse perception about taking charge.
T0 (baseline) and T1 (after 3 months)
Acceptability of SUPER Digital Platform
Time Frame: T1 (after 3 months of use of SUPER by parents, clinicians and teachers)
SUPER Questionnaire is an instrument created ad hoc to evaluate the acceptability of SUPER platform for parents, clinicians and teachers of children with ASD. It is composed by 38 items based on a 5-points Likert Scale. Higher scores (maximum 190) mean optimal acceptability of SUPER within the rehabilitative taking charge, while lower scores (minimum 38) mean a worse level of acceptability.
T1 (after 3 months of use of SUPER by parents, clinicians and teachers)
Usability of SUPER Digital Platform via System Usability Scale
Time Frame: T1 (after 3 months of use of SUPER by parents, clinicians and teachers)
SUS (System Usability Scale) is a standardized tool for measuring the perceived usability of an interactive system, such as websites, user interfaces, and web applications. It consists of 10 items that are scored on a Likert scale, from 1 (strongly disagree) to 5 (strongly agree). The SUS scores below 68 reveal usability issues with the system, while scores higher than 68 indicate acceptable levels of usability. More specifically, scores over 80 suggest an "excellent" usable system, scores between 68 and 80 can be considered "good", scores between 51 and 68 indicate "fair" results, scores below 51 are "poor", and scores below 36 reflect "unusable" systems.
T1 (after 3 months of use of SUPER by parents, clinicians and teachers)
Change from baseline at 3 months in the Parent Stress Index-Short Form (PSI-SF)
Time Frame: T0 (baseline) and T1 (after 3 months)
The Parenting Stress Index-Short Form (PSI-SF) is one of the most commonly used measures of parenting stress both in clinical and research contexts. The PSI-SF is a 36-item, self-report measure with three subscales: Parental Distress (PD), Parent-Child Dysfunctional Interaction (PCDI), and Difficult Child (DC). Items are scored using the following 5-point scale: 1) SA (Strongly Agree); 2) A (Agree); 3) NS (Not Sure); 4) D (Disagree); 5) SD (Strongly Disagree).The normal range of scores is between the 15th and 80th percentile. Scores at or above the 85th percentile are considered high and Defensive Reponding scores at 10 or below are considered extremely low.
T0 (baseline) and T1 (after 3 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efficacy of SUPER Digital Platform to support rehabilitation about adaptive behaviour in children with ASD by VABS-2
Time Frame: T0 (baseline), T2 (after 6 months)

Vineland Adaptive Behavior Scales- 2 (VABS-2) is designed to measure adaptive behavior in daily settings for children and adults from birth to 90 years of age. The Vineland-II items are arranged from 11 simple to more complex behavior subdomains across four main domains: Communication, Daily Living Skills, Socialization, and Motor Skills. It also provides an optional Maladaptive Behavior Index. Items are arranged in a developmental sequence within each subdomain, with each item rated on a 3-point scale (i.e., 0 = Behavior Never Performed, 1 = Behavior Sometimes or Partially Performed, or 2 = Behavior Usually or Habitually Performed).

The Adaptive Behavior Composite and domains yield age-based standard scores with a normative M=100 and SD=15, and subdomains yield standard scores with a M=15 and SD=3.

T0 (baseline), T2 (after 6 months)
Efficacy of SUPER Digital Platform to support rehabilitation about behaviour of ASD children by CBCL
Time Frame: T0 (baseline), T1 (after 3 months); T2 (after 6 months)
Child Behavior Checklist (CBCL) is a standardized questionnaires that provides information on six scales: affective problems, attention-deficit/hyperactivity, anxiety, oppositional defiance, somatic problems, and conduct problems. It has two separate forms, one for children 1.5-5 years old and one for children 6-18 years old. On both versions, there is a Total Problems score, as well as composites for Internalizing and Externalizing Problems. DSM-Oriented Scales were formed based on experts' ratings of how well the items fit DSM criteria for relevant Major and Dysthymia for Affective Problems, Anxiety Problems, Oppositional Defiant Problems, and Conduct Problems. The preschool version the DSM-Oriented scales are for Affective Problems, Anxiety Problems, Pervasive Developmental Problems, Attention-Deficit/Hyperactivity Problems, and Oppositional Defiant Problems.
T0 (baseline), T1 (after 3 months); T2 (after 6 months)
Efficacy of SUPER Digital Platform to support the improvement of autistic symptoms in ASD children by CARS-2
Time Frame: T0 (baseline), T2 (after 6 months)
Childhood Autism Rating Scale - Second Edition (CARS-2) is extremely useful in identifying symptoms of autism. The clinician rates the individual on each item (15 items), using a 4-point response scale. Ratings are based not only on the frequency of the behavior in question, but also on its intensity, peculiarity, and duration.Scores above the cutoff (28) can be broken down into "mild-to-moderate" level of autistic behaviors vs. "severe" level.
T0 (baseline), T2 (after 6 months)
Efficacy of SUPER Digital Platform to support the improvement of social communication ASD children by SCQ
Time Frame: T0 (baseline), T1 (after 3 months), T2 (after 6 months)
SCQ is a parent-report tool to evaluate communication skills and social functioning in children who may have autism or autism spectrum disorders. The questionnaire is composed of just 40 yes-or-no questions. Both forms can be given directly to the parent, who can answer the questions without supervision. Higher scores mean a worse functioning. It produces results that can be helpful in treatment planning, educational intervention, and measurement of change over time.
T0 (baseline), T1 (after 3 months), T2 (after 6 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Renata Nacinovich, MD, University of Milano Bicocca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 9, 2022

Primary Completion (ANTICIPATED)

September 9, 2023

Study Completion (ANTICIPATED)

April 30, 2024

Study Registration Dates

First Submitted

May 9, 2022

First Submitted That Met QC Criteria

July 21, 2022

First Posted (ACTUAL)

July 26, 2022

Study Record Updates

Last Update Posted (ACTUAL)

November 25, 2022

Last Update Submitted That Met QC Criteria

November 23, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on SUPER digital platform

Subscribe